Selected research
Market Outlook & Growth Opportunities
Global Nootropic Food Ingredients Market Outlook and Growth Opportunities 2026
Market perspective
The global Nootropic Food Ingredients market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Nootropic Food Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Nootropic Food Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nootropic Food Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Nootropic Food Ingredients market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Nootropic Food Ingredients market include Lonza Group, DSM Firmenich, Glanbia Nutritionals, Kerry Group, Ingredion Inc, Cargill Inc, Indena S.p.A, Sabinsa Corporation and Balchem Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Nootropic Food Ingredients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Nootropic Food Ingredients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Nootropic Food Ingredients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nootropic Food Ingredients market size, projected growth trends, production technologies, key applications, and end-use industries.
Nootropic Food Ingredients Segment by Company
Lonza Group
DSM Firmenich
Glanbia Nutritionals
Kerry Group
Ingredion Inc
Cargill Inc
Indena S.p.A
Sabinsa Corporation
Balchem Corporation
Givaudan
Arla Food Ingredients
PLT Health Solutions
Natreon
Kyowa Hakko Bio Co., Ltd
Archer Daniels Midland
BASF SE
Kemin Corporation
Ixoreal Biomed
Beijing Gingko Group
Wuxi Cima Science Co., Ltd.
Nootropic Food Ingredients Segment by Type
Amino Acids and Derivatives
Botanical Extracts
Vitamins and Minerals
Synthetic Nootropis
Others
Nootropic Food Ingredients Segment by Application
Dietary Supplements
Functional Food and Beverages
Sport Nutrition
Clinical and Medical Nutrition
Others
Nootropic Food Ingredients Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Nootropic Food Ingredients status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Nootropic Food Ingredients market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Nootropic Food Ingredients significant trends, drivers, influence factors in global and regions.
6. To analyze Nootropic Food Ingredients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nootropic Food Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nootropic Food Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nootropic Food Ingredients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Nootropic Food Ingredients market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nootropic Food Ingredients industry.
Chapter 3: Detailed analysis of Nootropic Food Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Nootropic Food Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Nootropic Food Ingredients in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Amino Acids and Derivatives
- Botanical Extracts
- Vitamins and Minerals
- Synthetic Nootropis
- Others
Applications
- Dietary Supplements
- Functional Food and Beverages
- Sport Nutrition
- Clinical and Medical Nutrition
- Others
Companies covered
- Lonza Group
- DSM Firmenich
- Glanbia Nutritionals
- Kerry Group
- Ingredion Inc
- Cargill Inc
- Indena S.p.A
- Sabinsa Corporation
- Balchem Corporation
- Givaudan
- Arla Food Ingredients
- PLT Health Solutions
- Natreon
- Kyowa Hakko Bio Co., Ltd
- Archer Daniels Midland
- BASF SE
- Kemin Corporation
- Ixoreal Biomed
- Beijing Gingko Group
- Wuxi Cima Science Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Nootropic Food Ingredients Sales Value (2021-2032)
- 1.2.2 Global Nootropic Food Ingredients Sales Volume (2021-2032)
- 1.2.3 Global Nootropic Food Ingredients Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Nootropic Food Ingredients Market Dynamics
- 2.1 Nootropic Food Ingredients Industry Trends
- 2.2 Nootropic Food Ingredients Industry Drivers
- 2.3 Nootropic Food Ingredients Industry Opportunities and Challenges
- 2.4 Nootropic Food Ingredients Industry Restraints
3 Nootropic Food Ingredients Market by Company
- 3.1 Global Nootropic Food Ingredients Company Revenue Ranking in 2025
- 3.2 Global Nootropic Food Ingredients Revenue by Company (2021-2026)
- 3.3 Global Nootropic Food Ingredients Sales Volume by Company (2021-2026)
- 3.4 Global Nootropic Food Ingredients Average Price by Company (2021-2026)
- 3.5 Global Nootropic Food Ingredients Company Ranking (2024-2026)
- 3.6 Global Nootropic Food Ingredients Company Manufacturing Base and Headquarters
- 3.7 Global Nootropic Food Ingredients Company Product Type and Application
- 3.8 Global Nootropic Food Ingredients Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Nootropic Food Ingredients Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Nootropic Food Ingredients Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Nootropic Food Ingredients Market by Type
- 4.1 Nootropic Food Ingredients Type Introduction
- 4.1.1 Amino Acids and Derivatives
- 4.1.2 Botanical Extracts
- 4.1.3 Vitamins and Minerals
- 4.1.4 Synthetic Nootropis
- 4.1.5 Others
- 4.2 Global Nootropic Food Ingredients Sales Volume by Type
- 4.2.1 Global Nootropic Food Ingredients Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Nootropic Food Ingredients Sales Volume by Type (2021-2032)
- 4.2.3 Global Nootropic Food Ingredients Sales Volume Share by Type (2021-2032)
- 4.3 Global Nootropic Food Ingredients Sales Value by Type
- 4.3.1 Global Nootropic Food Ingredients Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Nootropic Food Ingredients Sales Value by Type (2021-2032)
- 4.3.3 Global Nootropic Food Ingredients Sales Value Share by Type (2021-2032)
5 Nootropic Food Ingredients Market by Application
- 5.1 Nootropic Food Ingredients Application Introduction
- 5.1.1 Dietary Supplements
- 5.1.2 Functional Food and Beverages
- 5.1.3 Sport Nutrition
- 5.1.4 Clinical and Medical Nutrition
- 5.1.5 Others
- 5.2 Global Nootropic Food Ingredients Sales Volume by Application
- 5.2.1 Global Nootropic Food Ingredients Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Nootropic Food Ingredients Sales Volume by Application (2021-2032)
- 5.2.3 Global Nootropic Food Ingredients Sales Volume Share by Application (2021-2032)
- 5.3 Global Nootropic Food Ingredients Sales Value by Application
- 5.3.1 Global Nootropic Food Ingredients Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Nootropic Food Ingredients Sales Value by Application (2021-2032)
- 5.3.3 Global Nootropic Food Ingredients Sales Value Share by Application (2021-2032)
6 Nootropic Food Ingredients Regional Sales and Value Analysis
- 6.1 Global Nootropic Food Ingredients Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Nootropic Food Ingredients Sales by Region (2021-2032)
- 6.2.1 Global Nootropic Food Ingredients Sales by Region: 2021-2026
- 6.2.2 Global Nootropic Food Ingredients Sales by Region (2027-2032)
- 6.3 Global Nootropic Food Ingredients Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Nootropic Food Ingredients Sales Value by Region (2021-2032)
- 6.4.1 Global Nootropic Food Ingredients Sales Value by Region: 2021-2026
- 6.4.2 Global Nootropic Food Ingredients Sales Value by Region (2027-2032)
- 6.5 Global Nootropic Food Ingredients Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Nootropic Food Ingredients Sales Value (2021-2032)
- 6.6.2 North America Nootropic Food Ingredients Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Nootropic Food Ingredients Sales Value (2021-2032)
- 6.7.2 Europe Nootropic Food Ingredients Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Nootropic Food Ingredients Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Nootropic Food Ingredients Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Nootropic Food Ingredients Sales Value (2021-2032)
- 6.9.2 South America Nootropic Food Ingredients Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Nootropic Food Ingredients Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Nootropic Food Ingredients Sales Value Share by Country, 2025 VS 2032
7 Nootropic Food Ingredients Country-level Sales and Value Analysis
- 7.1 Global Nootropic Food Ingredients Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Nootropic Food Ingredients Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Nootropic Food Ingredients Sales by Country (2021-2032)
- 7.3.1 Global Nootropic Food Ingredients Sales by Country (2021-2026)
- 7.3.2 Global Nootropic Food Ingredients Sales by Country (2027-2032)
- 7.4 Global Nootropic Food Ingredients Sales Value by Country (2021-2032)
- 7.4.1 Global Nootropic Food Ingredients Sales Value by Country (2021-2026)
- 7.4.2 Global Nootropic Food Ingredients Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.9.2 France Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.16.2 China Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.19.2 India Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Nootropic Food Ingredients Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Nootropic Food Ingredients Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Nootropic Food Ingredients Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Lonza Group
- 8.1.1 Lonza Group Company Information
- 8.1.2 Lonza Group Business Overview
- 8.1.3 Lonza Group Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Lonza Group Nootropic Food Ingredients Product Portfolio
- 8.1.5 Lonza Group Recent Developments
- 8.2 DSM Firmenich
- 8.2.1 DSM Firmenich Company Information
- 8.2.2 DSM Firmenich Business Overview
- 8.2.3 DSM Firmenich Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.2.4 DSM Firmenich Nootropic Food Ingredients Product Portfolio
- 8.2.5 DSM Firmenich Recent Developments
- 8.3 Glanbia Nutritionals
- 8.3.1 Glanbia Nutritionals Company Information
- 8.3.2 Glanbia Nutritionals Business Overview
- 8.3.3 Glanbia Nutritionals Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Glanbia Nutritionals Nootropic Food Ingredients Product Portfolio
- 8.3.5 Glanbia Nutritionals Recent Developments
- 8.4 Kerry Group
- 8.4.1 Kerry Group Company Information
- 8.4.2 Kerry Group Business Overview
- 8.4.3 Kerry Group Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Kerry Group Nootropic Food Ingredients Product Portfolio
- 8.4.5 Kerry Group Recent Developments
- 8.5 Ingredion Inc
- 8.5.1 Ingredion Inc Company Information
- 8.5.2 Ingredion Inc Business Overview
- 8.5.3 Ingredion Inc Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Ingredion Inc Nootropic Food Ingredients Product Portfolio
- 8.5.5 Ingredion Inc Recent Developments
- 8.6 Cargill Inc
- 8.6.1 Cargill Inc Company Information
- 8.6.2 Cargill Inc Business Overview
- 8.6.3 Cargill Inc Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Cargill Inc Nootropic Food Ingredients Product Portfolio
- 8.6.5 Cargill Inc Recent Developments
- 8.7 Indena S.p.A
- 8.7.1 Indena S.p.A Company Information
- 8.7.2 Indena S.p.A Business Overview
- 8.7.3 Indena S.p.A Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Indena S.p.A Nootropic Food Ingredients Product Portfolio
- 8.7.5 Indena S.p.A Recent Developments
- 8.8 Sabinsa Corporation
- 8.8.1 Sabinsa Corporation Company Information
- 8.8.2 Sabinsa Corporation Business Overview
- 8.8.3 Sabinsa Corporation Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Sabinsa Corporation Nootropic Food Ingredients Product Portfolio
- 8.8.5 Sabinsa Corporation Recent Developments
- 8.9 Balchem Corporation
- 8.9.1 Balchem Corporation Company Information
- 8.9.2 Balchem Corporation Business Overview
- 8.9.3 Balchem Corporation Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Balchem Corporation Nootropic Food Ingredients Product Portfolio
- 8.9.5 Balchem Corporation Recent Developments
- 8.10 Givaudan
- 8.10.1 Givaudan Company Information
- 8.10.2 Givaudan Business Overview
- 8.10.3 Givaudan Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Givaudan Nootropic Food Ingredients Product Portfolio
- 8.10.5 Givaudan Recent Developments
- 8.11 Arla Food Ingredients
- 8.11.1 Arla Food Ingredients Company Information
- 8.11.2 Arla Food Ingredients Business Overview
- 8.11.3 Arla Food Ingredients Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Arla Food Ingredients Nootropic Food Ingredients Product Portfolio
- 8.11.5 Arla Food Ingredients Recent Developments
- 8.12 PLT Health Solutions
- 8.12.1 PLT Health Solutions Company Information
- 8.12.2 PLT Health Solutions Business Overview
- 8.12.3 PLT Health Solutions Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.12.4 PLT Health Solutions Nootropic Food Ingredients Product Portfolio
- 8.12.5 PLT Health Solutions Recent Developments
- 8.13 Natreon
- 8.13.1 Natreon Company Information
- 8.13.2 Natreon Business Overview
- 8.13.3 Natreon Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Natreon Nootropic Food Ingredients Product Portfolio
- 8.13.5 Natreon Recent Developments
- 8.14 Kyowa Hakko Bio Co., Ltd
- 8.14.1 Kyowa Hakko Bio Co., Ltd Company Information
- 8.14.2 Kyowa Hakko Bio Co., Ltd Business Overview
- 8.14.3 Kyowa Hakko Bio Co., Ltd Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Kyowa Hakko Bio Co., Ltd Nootropic Food Ingredients Product Portfolio
- 8.14.5 Kyowa Hakko Bio Co., Ltd Recent Developments
- 8.15 Archer Daniels Midland
- 8.15.1 Archer Daniels Midland Company Information
- 8.15.2 Archer Daniels Midland Business Overview
- 8.15.3 Archer Daniels Midland Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Archer Daniels Midland Nootropic Food Ingredients Product Portfolio
- 8.15.5 Archer Daniels Midland Recent Developments
- 8.16 BASF SE
- 8.16.1 BASF SE Company Information
- 8.16.2 BASF SE Business Overview
- 8.16.3 BASF SE Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.16.4 BASF SE Nootropic Food Ingredients Product Portfolio
- 8.16.5 BASF SE Recent Developments
- 8.17 Kemin Corporation
- 8.17.1 Kemin Corporation Company Information
- 8.17.2 Kemin Corporation Business Overview
- 8.17.3 Kemin Corporation Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Kemin Corporation Nootropic Food Ingredients Product Portfolio
- 8.17.5 Kemin Corporation Recent Developments
- 8.18 Ixoreal Biomed
- 8.18.1 Ixoreal Biomed Company Information
- 8.18.2 Ixoreal Biomed Business Overview
- 8.18.3 Ixoreal Biomed Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Ixoreal Biomed Nootropic Food Ingredients Product Portfolio
- 8.18.5 Ixoreal Biomed Recent Developments
- 8.19 Beijing Gingko Group
- 8.19.1 Beijing Gingko Group Company Information
- 8.19.2 Beijing Gingko Group Business Overview
- 8.19.3 Beijing Gingko Group Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Beijing Gingko Group Nootropic Food Ingredients Product Portfolio
- 8.19.5 Beijing Gingko Group Recent Developments
- 8.20 Wuxi Cima Science Co., Ltd.
- 8.20.1 Wuxi Cima Science Co., Ltd. Company Information
- 8.20.2 Wuxi Cima Science Co., Ltd. Business Overview
- 8.20.3 Wuxi Cima Science Co., Ltd. Nootropic Food Ingredients Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Wuxi Cima Science Co., Ltd. Nootropic Food Ingredients Product Portfolio
- 8.20.5 Wuxi Cima Science Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Nootropic Food Ingredients Value Chain Analysis
- 9.1.1 Nootropic Food Ingredients Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Nootropic Food Ingredients Sales Mode & Process
- 9.2 Nootropic Food Ingredients Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Nootropic Food Ingredients Distributors
- 9.2.3 Nootropic Food Ingredients Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst